Moving Microbiome Science from the Bench to the Bedside: a Physician-Scientist Perspective
The recognition over the past decade that nearly all diseases are associated with changes in the microbiome has raised hope that microbiome-based therapeutics may cure many human ailments. Billions of dollars are being poured into microbiome-oriented biotech companies, and the coming years will undo...
Main Author: | Neeraj K. Surana |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2019-05-01
|
Series: | mSystems |
Subjects: | |
Online Access: | https://doi.org/10.1128/mSystems.00160-19 |
Similar Items
-
The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside
by: Tomislav Meštrović, et al.
Published: (2021-12-01) -
Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside
by: Rosalba Mansi, et al.
Published: (2021-06-01) -
Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside
by: Gabriel Siracusano, et al.
Published: (2020-01-01) -
From bench to bedside and to health policies (and back): ethics in translational research
by: Carlo Petrini
Published: (2014-03-01) -
Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again
by: Mitsuru Arima, et al.
Published: (2021-01-01)